The largest database of trusted experimental protocols

7 protocols using anti fibrinogen

1

Immunohistochemical Analysis of Neuroinflammation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh-frozen sections were fixed with either 50% MeOH and 50% acetone for 10 min at −20°c or 4% PFA. The primary antibodies used were: anti-GFAP (DAKO Z0334); anti-CD11b (Abcam ab-8878); anti-TMEM (Abcam ab209064); anti-PECAM1 (BD Pharmingen 550274); anti-CD68 (AbD Serotec MCA1957GA); anti-CD206 (Thermo PA5–46994); anti-Fibrinogen (Dako A0080); IgG (Thermo scientific); anti-laminin (Fisher scientific RT-795-PO); and anti-iNOS (Abcam ab-129372). For secondary antibodies, we used IgG (Thermo Scientific) from donkey anti- mouse, -rat, -rabbit or -goat, depending on the host of the primary antibody. Vectasheild-DAPI (Vector Labs) was used to seal the slides. Brain sections were visualized using Zeiss Axiovert200. Images were analyzed using ImageJ software.
+ Open protocol
+ Expand
2

Multimodal Immunolabeling of Diverse CNS Targets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Catalogue numbers and concentrations of all antibodies are as follows. Anti-GFAP (130300, rat, 1:200), anti-occludin (711500, rabbit, 1:125) and anti-IgG (A11029, mouse, 1:100) were from Invitrogen. Anti–JAM-A (sc53623, mouse, 1:100) was from Santa Cruz Biotechnology. Fluoromyelin was from ThermoFisher (F34651, 1:300). Anti-fibrinogen (A0080, rabbit, 1:150) was from Dako. Anti-CD3 (16-0037-85, mouse, 1:100), anti-CD4 (14-9766-82, rat, 1:100), Anti-CD31 (550274, rat, 1:100), anti-CD45 (550539, rat, 1:100) were from eBioscience. anti-CD4 (ab183685, mouse, 1:50) was from Abcam. Anti-NeuN (MAB377, mouse, 1:100), anti-Olig2 (MABN50, mouse, 1:500) and anti-AQP4 (AB3594, rabbit, 1:200) were from Millipore. Anti-laminin (L9393, rabbit, 1:200) was from Sigma–Aldrich. Anti-Iba1 (109-19741, rabbit, 1:500) was from Wako.
+ Open protocol
+ Expand
3

Multimodal Labeling of Brain Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fixed brain hemispheres were cut into 40 µm sagittal sections with a vibratome (Leica). Sections were incubated with primary antibodies and were incubated overnight at 4°C, including anti-Aβ MOAB-2 (6C3) (Millipore) at 1:1000; and anti-GFAP (Invitrogen) at 1:500, anti-Iba1 (Wako) at 1:500; anti-synaptophysin (Santa Cruz) at 1:200, anti-pan-laminin (Sigma) at 1:300; anti-fibrinogen (Dako) at 1:2000; anti-AQP4 (Santa Cruz) at 1:100 or 1:200; anti-occludin (Invitrogen) at 1:100 in 2% normal horse serum in Tris-buffered saline (TBS)-Triton 0.02%. The following day, sections were incubated with appropriate secondary antibodies (1:400; Vector), followed by enhancement with avidin-biotin complex (ABC; Vector) and 3,3′-diaminobenzidine (DAB; Sigma). Images were acquired with a Leica DM2500 microscope connected to a camera (Q-Imaging Micropublisher 3.3 RTV) using Q-capture Pro software. For immunofluorescence, fluorescent secondary antibodies (1:400 Alexa Fluor®, Invitrogen) were used. In some cases, staining with 647-labelled tomato lectin (Vector Labs) was carried out simultaneously with secondary antibody incubation. For Thioflavin S staining, sections were incubated with 1% Thioflavin S (Sigma) for 8 min before being washed with ethanol and H2O.
+ Open protocol
+ Expand
4

Platelet Reactivity Assay by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Platelet count and parameters were determined using an automated hematology analyzer (Sysmex, Kobe, Japan). Platelet reactivity was determined in citrated whole blood (3.2% sodium citrate, Becton Dickinson, Franklin Lakes, NJ, USA) using a flow cytometry based assay as previously described between 1 and 3 h after blood collection52 (link). Platelets were ex vivo stimulated with ADP (1.2 and 125 μM; Sigma-Aldrich, Zwijndrecht, The Netherlands) and CRP-XL (a kind gift from Prof. Farndale, Cambridge, UK) for 20 min at room temperature. Platelets were stained using anti-CD61 (Beckman Coulter, Brea. CA, USA), anti-P-selectin (Biolegend, San Diego, CA, USA) and anti-fibrinogen (DAKO, Santa Clara, CA) antibodies and fixated in 0.2% paraformaldehyde. Platelets were identified based on Size (FSC), granularity (SSC) and their expression of CD61. Degranulation was determined as the membrane expression of α-granule protein P-selectin and platelet aggregation was quantified as the amount of fibrinogen binding to the activated integrin αIIbβ3. Platelet reactivity was measured on a FC500 flow cytometer (Beckman Coulter, Brea, USA). Data were extracted using Kaluza 2.1 (Beckman Coulter), normalized against quality controls to ensure measurement stability and are expressed as median fluorescence intensity (MFI). A gating strategy is provided in Supplemental Fig. S1.
+ Open protocol
+ Expand
5

Immunostaining of Thrombosis Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly recovered thrombi were fixed in 3.7% paraformaldehyde for 48 h before being embedded longitudinally in paraffin and sectioned at 5 µm. Immunostainings were performed as described previously27 (link) using the following primary antibodies: anti‐fibrinogen (20 µg/ml; Dako, ref A0080), anti‐Von Willebrand factor (10 µg/ml; Abcam, ref ab11713), anti‐CD42b (2 µg/ml; Beckman Coulter, ref IM0409), anti‐platelet factor 4 (10 µg/ml; Peprotech, ref 500‐P05), anti‐myeloperoxidase (MPO, 10 µg/ml; Dako, ref A0398), anti‐histone H4 citrulline 3 (H4Cit, 1/200; Millipore, ref 07‐596), anti‐angiotensin‐converting enzyme 2 (ACE‐2, 3 µg/ml, R&D Systems, ref AF933), and anti‐SARS‐CoV‐2 Spike Protein (5 µg/ml, P06DHuRb and T01KHuRb from Invitrogen, 10 µg/ml 40150‐R007 from Sino Biological). Red blood cells were identified by their autofluorescence (λex 440/9/λem > 570 nm).
+ Open protocol
+ Expand
6

Quantifying Vascular Permeability Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
IgG and albumin extravasation. Brains were cut serially in 20-μm cryosections. Four sections per brain, two at the striatum (0.26 mm and 0.92 mm posterior to the bregma) and another two at the dorsal hippocampus (3.14 mm and 4.16 mm posterior to the bregma) according to a rat brain atlas, were selected for staining. The brain sections were incubated with primary anti-IgG antibody (HRP-conjugated 1:200; AP136P, Chemicon) or anti-albumin antibody (1:200, Genetex) for 2 h at room temperature. Biotin-peroxidase signals were detected using 0.5 mg/mL 3′3′-diaminobenzidine (DAB)/0.003% H2O2 as a substrate and were microscopically recorded (Eclipse E400, Nikon). The integrated optic density of IgG and albumin signals were further analyzed and the averaged value at three visual fields in the cortex per sections at ×200 magnification (0.145 mm2/per visual field).
Fibrin leakage. Brain cryosections were probed with primary antibodies, anti-fibrinogen (1:200 Dako) and anti-RECA antiboties (1:100 Abcam) as described in the previous immunefluorescence method.
+ Open protocol
+ Expand
7

Antibody Panel for Alzheimer's Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were utilised in our study: 6E10 (against Aβ1–16) from Covance; MOAB-2 clone 6C3 against Aβ from Merck-Millipore (Burlington, MA, USA); anti-apolipoprotein E (ApoE) and Aquaporin-4 (AQP-4) from Santa Cruz; anti-insulin-degrading enzyme (IDE) and anti-β-actin from Abcam; anti-ionized calcium-binding adaptor molecule 1 (Iba1) from Wako; anti-CD68 from Biolegend; Rat anti-GFAP (clone 2.2B10) from Invitrogen or from DAKO; anti-fibrinogen from DAKO and anti-CD31 from BD Biosciences. All other reagents were purchased from Invitrogen or Sigma, unless otherwise indicated.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!